发明名称 REVERSIBLE PEGYLATED DRUGS
摘要 Reversible pegylated drugs are provided by derivatization of free functional groups of the drug selected from amino, hydroxyl, mercapto, phosphate and/or carboxyl with groups sensitive to mild basic conditions such as 9-fluorenylmethoxycarbonyl (Fmoc) or 2-sulfo-9-fluorenylmethoxycarbonyl (FMS), to which group a PEG moiety is attached. In these pegylated drugs, the PEG moiety and the drug residue are not linked directly to each other, but rather both residues are linked to different positions of the scaffold Fmoc or FMS structure that is highly sensitive to bases and is removable under physiological conditions. The drugs are preferably drugs containing an amino group, most preferably peptides and proteins of low or medium molecular weight.
申请公布号 CA2843439(A1) 申请公布日期 2004.10.21
申请号 CA20042843439 申请日期 2004.04.08
申请人 YEDA RESEARCH AND DEVELOPMENT CO. LTD 发明人 SHECHTER, YORAM;FRIDKIN, MATITYAHU;TSUBERY, HAIM
分类号 A61K47/48;A61K;A61K38/00;A61K38/28;A61K38/43;A61P3/08;A61P3/10 主分类号 A61K47/48
代理机构 代理人
主权项
地址